InvestorsHub Logo
Replies to #523 on Biotech Values

DewDiligence

12/03/03 2:41 PM

#524 RE: rwwine #523

rwwine: There will not be any 6-month results. The phase 1/2 Squalamine trial in AMD ended with the 4-month evaluation.